Chemistry:ABT-202

From HandWiki
Short description: Chemical compound
ABT-202
ABT-202.svg
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC9H13N3
Molar mass163.219 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.[1][2][3]

References

  1. "Modulators of nicotinic acetylcholine receptors as analgesics". Current Opinion in Investigational Drugs 5 (1): 76–81. January 2004. PMID 14983978. 
  2. "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–67. June 2007. doi:10.1002/cmdc.200600207. PMID 17295372. 
  3. "Automated 96-well liquid-liquid back extraction liquid chromatography-tandem mass spectrometry method for the determination of ABT-202 in human plasma". Journal of Pharmaceutical and Biomedical Analysis 36 (1): 189–95. September 2004. doi:10.1016/j.jpba.2004.05.013. PMID 15351065.